BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 22008952)

  • 1. Developmental toxicity testing in the 21st century: the sword of Damocles shattered by embryonic stem cell assays?
    Seiler A; Oelgeschläger M; Liebsch M; Pirow R; Riebeling C; Tralau T; Luch A
    Arch Toxicol; 2011 Nov; 85(11):1361-72. PubMed ID: 22008952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Commentary on ''Toxicity testing in the 21st century: a vision and a strategy'': stem cells and cell-cell communication as fundamental targets in assessing the potential toxicity of chemicals.
    Trosko JE
    Hum Exp Toxicol; 2010 Jan; 29(1):21-9. PubMed ID: 20061464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The embryonic stem cell test combined with toxicogenomics as an alternative testing model for the assessment of developmental toxicity.
    van Dartel DA; Piersma AH
    Reprod Toxicol; 2011 Sep; 32(2):235-44. PubMed ID: 21575713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicology in the 21st century--working our way towards a visionary reality.
    Berg N; De Wever B; Fuchs HW; Gaca M; Krul C; Roggen EL
    Toxicol In Vitro; 2011 Jun; 25(4):874-81. PubMed ID: 21338664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Commentary on ''Toxicity testing in the 21st century: a vision and a strategy''.
    Phalen RF
    Hum Exp Toxicol; 2010 Jan; 29(1):11-4. PubMed ID: 20061462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation challenges for designing integrated in vitro testing strategies (ITS) aiming at reducing and replacing animal experimentation.
    De Wever B; Fuchs HW; Gaca M; Krul C; Mikulowski S; Poth A; Roggen EL; Vilà MR
    Toxicol In Vitro; 2012 Apr; 26(3):526-34. PubMed ID: 22269383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative test methods in inhalation toxicology: challenges and opportunities.
    Costa DL
    Exp Toxicol Pathol; 2008 Jun; 60(2-3):105-9. PubMed ID: 18486462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative methods for developmental toxicity testing.
    Piersma AH
    Basic Clin Pharmacol Toxicol; 2006 May; 98(5):427-31. PubMed ID: 16635099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
    Lilienblum W; Dekant W; Foth H; Gebel T; Hengstler JG; Kahl R; Kramer PJ; Schweinfurth H; Wollin KM
    Arch Toxicol; 2008 Apr; 82(4):211-36. PubMed ID: 18322675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Commentary on ''Toxicity testing in the 21st century: a vision and a strategy''.
    Schwartz SL
    Hum Exp Toxicol; 2010 Jan; 29(1):15-9. PubMed ID: 20061463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Commentary on ''Toxicity testing in the 21st century: a vision and a strategy''.
    Waddell WJ
    Hum Exp Toxicol; 2010 Jan; 29(1):31-2. PubMed ID: 20061465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementing Toxicity Testing in the 21st Century (TT21C): Making safety decisions using toxicity pathways, and progress in a prototype risk assessment.
    Adeleye Y; Andersen M; Clewell R; Davies M; Dent M; Edwards S; Fowler P; Malcomber S; Nicol B; Scott A; Scott S; Sun B; Westmoreland C; White A; Zhang Q; Carmichael PL
    Toxicology; 2015 Jun; 332():102-11. PubMed ID: 24582757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein biomarkers for in vitro testing of toxicology.
    Schrattenholz A; Šoškić V; Schöpf R; Poznanović S; Klemm-Manns M; Groebe K
    Mutat Res; 2012 Aug; 746(2):113-23. PubMed ID: 22405942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An integrated summary of commentary on the National Academy of Sciences report on ''Toxicity testing in the 21st century: a vision and a strategy''.
    Gibson JE
    Hum Exp Toxicol; 2010 Jan; 29(1):33-5. PubMed ID: 20061466
    [No Abstract]   [Full Text] [Related]  

  • 15. Toxicity testing in the 21st century: how will it affect risk assessment?
    Rhomberg LR
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):361-75. PubMed ID: 20574908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicity testing in the 21st century: bringing the vision to life.
    Andersen ME; Krewski D
    Toxicol Sci; 2009 Feb; 107(2):324-30. PubMed ID: 19074763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From alternative methods to a new toxicology.
    Hartung T
    Eur J Pharm Biopharm; 2011 Apr; 77(3):338-49. PubMed ID: 21195172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on the validation of application model on embryonic stem test].
    Yu Z; Yan W; Zhang L; Xu H
    Wei Sheng Yan Jiu; 2008 Sep; 37(5):570-3. PubMed ID: 19069656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endless possibilities: stem cells and the vision for toxicology testing in the 21st century.
    Chapin RE; Stedman DB
    Toxicol Sci; 2009 Nov; 112(1):17-22. PubMed ID: 19703945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How omics technologies can contribute to the '3R' principles by introducing new strategies in animal testing.
    Kroeger M
    Trends Biotechnol; 2006 Aug; 24(8):343-6. PubMed ID: 16782220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.